Read Post Market Analysis published at 4 pm everday. click here
  1. home
  2. Company
  3. Lupin
  4. Financials

Pivot Points
08 Jul 2020 03:35 PM IST
Name S3 S2 S1 Pivot Points R1 R2 R3
Fibonacci 856.83 863.40 867.46 874.03 880.60 884.66 891.23
Bollinger band (1,2) - 905.66 913.16 913.16 913.16 920.66 -

Technical Indicator
Name Value
Adx(14) 46.05
Rsi(14) 46.05
Stoch Rsi(14) 0.56
MACD(12,26) -1.65
Williams %R -69.00
ROC -0.99
Moving Averages
Period Simple Exponential
MA 9 896.74 890.63
MA 20 913.16 899.55
MA 50 884.86 872.40
MA 100 785.43 827.25
MA 200 765.80 790.94
Related News

Buy Lupin, target price Rs 1,040: Nomura

update 09 Jul 01:57 PM

In FY21F the company is also likely to incur one-time additional expenses of $10 million related to the recall of Metformin extended-release tablets from the US market.

Lupin recalls diabetes treatment drug in the US

update 08 Jul 11:55 AM

In a regulatory filing, the company said that it is voluntarily recalling its Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg products in the US.

Lupin recalls diabetes treatment drug in US

update 08 Jul 11:44 AM

Drug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tablets in the US market.

Stocks in the news: Reliance Ind, ICICI Bank, Future Retail, Indiabulls Housing, YES Bank, Biocon and NBCC

update 06 Jul 07:26 AM

Lupin, Marksans Pharma, Aurobindo Pharma and Alembic Pharmaceuticals are recalling products in the US market.

Indian drug firms recall products in US market

update 05 Jul 03:45 PM

While Lupin and Marksans Pharma are recalling diabetes drug, Aurobindo and Alembic are recalling psychiatric medication in the US market.

Replacing China as API supplier for pharma will be a medium to long term story: Lupin

update 26 Jun 05:19 PM

‘In the case of Lupin, the actual API import from China is on the lower side.’

Share market update: Pharma shares up; Lupin rises 2%

update 25 Jun 12:06 PM

The Nifty Pharma index was trading 0.09 per cent up at 10119.7.

D-Street Buzz: Pharma stocks rally; Glenmark zooms 35%, Cipla, Sun Pharma, Biocon gain

update 22 Jun 12:45 PM

Cipla jumped over 4 percent after the country's drug regulator on June 20 gave permission to Hetero and Cipla to manufacture and market antiviral drug remdesivir while Lupin, Sun Pharma, Torrent Pharma, Biocon and Divis Labs were the other gainers.

Unichem, Lupin recall hypertension drugs in US

update 21 Jun 12:32 PM

As per the latest enforcement report issued by the US Food and Drug Administration (USFDA), Unichem is voluntarily recalling 1,90,992 bottles of Clonodine Hydrochloride tablets, which are used to treat high blood pressure.

India must manufacture more APIs locally, depend less on China: Experts

update 18 Jun 07:46 AM

India, the world’s third-largest drug producer by volumes, imports 70% of its APIs from China. For some APIs, especially antibiotics, dependence on China is over 90%. India’s top drug makers, including Dr Reddy’s, Lupin, Glenmark, Mylan, Zydus and Pfizer are dependent on China for APIs.


Open Zerodha account launch

( ₹ 20 / Trade )